Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
37.55M
Cash
6.324M
Avg Qtr Burn
-3.661M
Short % of Float
0.70%
Insider Ownership
47.16%
Institutional Own.
12.49%
Qtr Updated
06/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
INT230-6 Details Sarcoma | Phase 3 Data readout | |
INT230-6 Details Cancer, Triple-negative breast cancer , Solid tumor/s | Phase 2/3 Data readout | |
INT230-6 w/ Keytruda Details Pancreatic cancer, Colorectal cancer | Phase 2 Data readout | |
INT230-6 Details Breast cancer | Phase 2 Update | |
INT230-6 w/ Yervoy Details Liver cancer, Sarcoma, Breast cancer | Phase 2 Update |